BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 163686)

  • 1. Increased activity of low-Km cyclic adenosine 3':5'-monophosphate phosphodiesterase in plasma membranes of Morris hepatoma 5123tc (h).
    Hickie RA; Walker CM; Datta A
    Cancer Res; 1975 Mar; 35(3):601-5. PubMed ID: 163686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative adenylate cyclase activities in homogenate and plasma membrane fractions of Morris hepatoma 5123tc (h).
    Hickie RA; Jan SH; Datta A
    Cancer Res; 1975 Mar; 35(3):596-600. PubMed ID: 163685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic nucleotide phosphodiesterase activity in normal and neoplastic rat mammary cells grown in monolayer culture.
    Cohen LA; Straka D; Chan PC
    Cancer Res; 1976 Jun; 36(6):2007-12. PubMed ID: 178439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Some features of cyclic adenosine monophosphate metabolism in mouse liver and hepatoma 22].
    Solntseva TI; Belousova AK
    Biokhimiia; 1977 Jul; 42(7):1331-7. PubMed ID: 20168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic 3',5'-nucleotide monophosphate phosphodiesterase activity in hepatomas of different growth rates.
    Rhoads AR; Morris HP; West WL
    Cancer Res; 1972 Dec; 32(12):2651-5. PubMed ID: 4345399
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in malignant and cyclic adenosine 3':5'-monophosphate-induced "differentiated" neuroblastoma cells.
    Kumar S; Becker G; Prasad KN
    Cancer Res; 1975 Jan; 35(1):82-7. PubMed ID: 234030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic adenosine 3',5'-monophosphate phosphodiesterase activity in normal, differentiating, regenerating, and neoplastic liver.
    Clark JF; Morris HP; Weber G
    Cancer Res; 1973 Feb; 33(2):356-61. PubMed ID: 4347469
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of cyclic AMP phosphodiesterase by a new vitamin E derivative.
    Sakai T; Okano T; Makino H; Tsudzuki T
    J Cyclic Nucleotide Res; 1976; 2(3):163-70. PubMed ID: 180065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic 3',5'-adenosine monophosphate phosphodiesterase in the thymus of normal and leukemic mice.
    Menahan LA; Kemp RG
    J Cyclic Nucleotide Res; 1976; 2(6):417-25. PubMed ID: 190277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of enzymes by glucagon, glucose repression, adenosine 3',5'-monophosphate concentration during carcinogenesis and in Morris 6918A hepatoma.
    Sudilovsky O; Gunter R
    Cancer Res; 1975 Apr; 35(4):1069-74. PubMed ID: 234792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An effect of dexamethasone on adenosine 3',5'-monophosphate content and adenosine 3',5'-monophosphate phosphodiesterase activity of cultured hepatoma cells.
    Manganiello V; Vaughan M
    J Clin Invest; 1972 Oct; 51(10):2763-7. PubMed ID: 4341439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5'-Nucleotide phosphodiesterase activity in rat hepatoma.
    Tsou KC; Morris HP; Lo KW; Muscato JJ
    Cancer Res; 1974 Jun; 34(6):1295-8. PubMed ID: 4363652
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of cell division and of tyrosinase in B16 melanoma cells by imidazole: a possible role for the concept of metabolite gene regulation in mammalian cells.
    Montefiori DC; Kline EL
    J Cell Physiol; 1981 Feb; 106(2):283-91. PubMed ID: 6260821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclic nucleotide phosphodiesterase activity by an endogenous factor.
    Ho RJ; Russell TR; Asakawa T; Hucks MW
    J Cyclic Nucleotide Res; 1975; 1(2):81-8. PubMed ID: 177458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in glycosphingolipids of plasma membranes from Morris hepatoma 5123TC.
    Dnistrian AM; Skipski VP; Barclay M; Stock CC
    Cancer Res; 1977 Jul; 37(7 Pt 1):2182-7. PubMed ID: 193636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic nucleotide phosphodiesterases in neoplastic and nonneoplastic human mammary tissues.
    Singer AL; Sherwin RP; Dunn AS; Appleman MM
    Cancer Res; 1976 Jan; 36(1):60-6. PubMed ID: 174814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate.
    Cubeddu L; Barnes E; Weiner N
    J Pharmacol Exp Ther; 1975 Apr; 193(1):105-27. PubMed ID: 166157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP phosphodiesterase activity in three Morris hepatomas.
    Criss WE; Morris HP
    Enzyme; 1975; 20(2):65-70. PubMed ID: 165075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver.
    Heinrich PC; Morris HP; Weber G
    Cancer Res; 1976 Sep; 36(9 pt.1):3189-97. PubMed ID: 10080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Concentration and metabolism of cyclic AMP during the early stages of hepatoma 22a growth].
    Solntseva TI; Belousova AK
    Biull Eksp Biol Med; 1977 Oct; 84(10):472-4. PubMed ID: 199292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.